Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients
Clinical trial NCT03205267 · UNKNOWN
Trial details
- NCT number
- NCT03205267
- Sponsor
- University of Bonn
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-10-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.